Álvaro Aceña Selected Research

Calcifediol (Calcidiol)

10/2016	Circulating fibroblast growth factor-23 plasma levels predict adverse cardiovascular outcomes in patients with diabetes mellitus with coronary artery disease.
1/2016	Design and rationale of a multicentre, randomised, double-blind, placebo-controlled clinical trial to evaluate the effect of vitamin D on ventricular remodelling in patients with anterior myocardial infarction: the VITamin D in Acute Myocardial Infarction (VITDAMI) trial.
1/2016	Plasma Levels of Monocyte Chemoattractant Protein-1, n-Terminal Fragment of Brain Natriuretic Peptide and Calcidiol Are Independently Associated with the Complexity of Coronary Artery Disease.
7/2015	Differential profile in inflammatory and mineral metabolism biomarkers in patients with ischemic heart disease without classical coronary risk factors.
1/2014	Coexistence of low vitamin D and high fibroblast growth factor-23 plasma levels predicts an adverse outcome in patients with coronary artery disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Álvaro Aceña Research Topics

Disease

12	Coronary Artery Disease (Coronary Atherosclerosis) 01/2022 - 01/2014
8	Heart Failure 09/2021 - 07/2015
4	Acute Coronary Syndrome 01/2022 - 09/2016
3	Stroke (Strokes) 01/2022 - 01/2017
3	Atrial Fibrillation 09/2021 - 01/2015
3	ST Elevation Myocardial Infarction 01/2021 - 01/2016
3	Hypertension (High Blood Pressure) 01/2017 - 01/2015
2	Amyloidosis 02/2022 - 01/2021
2	Thrombosis (Thrombus) 01/2022 - 07/2015
2	Myocardial Infarction 01/2022 - 01/2016
2	Neoplasms (Cancer) 09/2021 - 01/2015
2	Inflammation (Inflammations) 03/2021 - 07/2015
2	Myocardial Ischemia (Ischemic Heart Diseases) 01/2021 - 07/2015
2	Dyslipidemias (Dyslipidemia) 01/2021 - 09/2020
1	Cognitive Dysfunction 01/2022
1	Heart Diseases (Heart Disease) 01/2022
1	Cardiovascular Diseases (Cardiovascular Disease) 03/2021
1	Disease Progression 02/2021
1	Severe Acute Respiratory Syndrome 02/2021
1	COVID-19 02/2021
1	Infections 02/2021
1	Left Ventricular Dysfunction 01/2021
1	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 01/2021
1	Aortic Valve Stenosis (Aortic Stenosis) 01/2021
1	Peripheral Arterial Disease 01/2021
1	Cardiogenic Shock 12/2020
1	Pathologic Dilatation (Ectasia) 09/2020
1	Myocardial Stunning (Stunned Myocardium) 11/2018
1	Diabetes Mellitus 10/2016
1	Vascular Calcification 09/2016
1	Chronic Kidney Disease-Mineral and Bone Disorder (Renal Rickets) 09/2016
1	Bone Diseases (Bone Disease) 09/2016
1	Chronic Renal Insufficiency 09/2016
1	Hyperlipidemias (Hyperlipidemia) 01/2016
1	Coronary Disease (Coronary Heart Disease) 03/2015
1	Heart Neoplasms 01/2015

Drug/Important Bio-Agent (IBA)

6	Biomarkers (Surrogate Marker)IBA 01/2022 - 07/2015
5	MineralsIBA 01/2022 - 01/2014
5	pro-brain natriuretic peptide (1-76)IBA 09/2021 - 01/2015
5	Brain Natriuretic Peptide (Natrecor)FDA Link 09/2021 - 01/2015
5	Calcifediol (Calcidiol)FDA Link 10/2016 - 01/2014
4	Parathyroid Hormone (Parathormone)IBA 01/2022 - 07/2015
4	C-Reactive ProteinIBA 03/2021 - 01/2015
3	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 09/2020 - 07/2015
3	LipidsIBA 09/2020 - 03/2015
3	Fibroblast Growth Factor-23IBA 10/2016 - 01/2014
3	Vitamin D FDA LinkGeneric 01/2016 - 01/2014
2	Prealbumin (Transthyretin)IBA 02/2022 - 01/2021
2	Phosphates (Orthophosphate)IBA 10/2016 - 07/2015
2	Galectin 3 (LGALS3)IBA 07/2015 - 03/2015
1	SDMIBA 02/2022
1	oxidized low density lipoproteinIBA 01/2021
1	Amyloid (Amyloid Fibrils)IBA 01/2021
1	Proteins (Proteins, Gene)FDA Link 01/2021
1	LDL CholesterolIBA 01/2021
1	Biological ProductsIBA 12/2020
1	Proprotein Convertase 9IBA 09/2020
1	CatecholaminesIBA 11/2018
1	Pravastatin (Pravachol)FDA LinkGeneric 08/2017
1	Proton Pump InhibitorsIBA 01/2017
1	Clopidogrel (Plavix)FDA Link 01/2017
1	NitratesIBA 01/2017
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2017
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2016
1	Triglycerides (Triacylglycerol)IBA 01/2015
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2015
1	Troponin IIBA 01/2015
1	Natriuretic PeptidesIBA 01/2015
1	trans-crotonin (CTN)IBA 01/2015
1	DiureticsIBA 01/2015
1	Insulin (Novolin)FDA Link 01/2015
1	TroponinIBA 01/2015

Therapy/Procedure

4	Therapeutics 01/2021 - 01/2015
1	Polypharmacy 01/2021
1	Percutaneous Coronary Intervention 01/2021